OptiBiotix Health Plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPTI.L research report →
Companywww.optibiotix.com
OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages.
- CEO
- Stephen Patrick O'Hara
- IPO
- 2011
- Employees
- 10
- HQ
- York, GB
Price Chart
Valuation
- Market Cap
- $5.97M
- P/E
- -30.97
- P/S
- 5.19
- P/B
- 0.70
- EV/EBITDA
- -69.70
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 36.49%
- Op Margin
- -229.11%
- Net Margin
- -16.59%
- ROE
- -2.27%
- ROIC
- -24.63%
Growth & Income
- Revenue
- $870.00K · 35.09%
- Net Income
- $-1,805,000 · 11.48%
- EPS
- $-0.02 · 18.58%
- Op Income
- $-2,266,000
- FCF YoY
- -15.78%
Performance & Tape
- 52W High
- $18.35
- 52W Low
- $4.50
- 50D MA
- $5.36
- 200D MA
- $7.57
- Beta
- 1.80
- Avg Volume
- 371.17K
Get TickerSpark's AI analysis on OPTI.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our OPTI.L Coverage
We haven't published any research on OPTI.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OPTI.L Report →